CNBX
CNBX Pharmaceuticals Inc.Company with tickers: CNBX
CIK
1343009
CUSIP
13764M209
Shares Outstanding
1,225,768,095
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-04-14 | 2026-02-28 | |
| 8-K | 2026-03-17 | 2026-03-10 | |
| 10-Q | 2026-01-14 | 2025-11-30 | |
| 10-K | 2025-12-01 | 2025-08-31 | |
| 10-Q | 2025-07-14 | 2025-05-31 | |
| 10-Q | 2025-04-14 | 2025-02-28 | |
| 8-K | 2025-01-30 | 2025-01-24 | |
| 10-Q | 2025-01-13 | 2024-11-30 | |
| 10-K | 2024-11-29 | 2024-08-31 | |
| 10-Q | 2024-07-15 | 2024-05-31 | |
| 10-Q | 2024-04-16 | 2024-02-29 | |
| 8-K | 2024-03-22 | 2024-03-18 | |
| 10-Q | 2024-01-12 | 2023-11-30 | |
| 10-K | 2023-11-30 | 2023-08-31 | |
| 10-Q | 2023-07-14 | 2023-05-31 | |
| 10-Q | 2023-04-14 | 2023-02-28 | |
| 8-K | 2023-02-08 | 2023-01-31 | |
| 10-Q | 2023-01-13 | 2022-11-30 | |
| 8-K | 2022-12-29 | 2022-12-25 | |
| 10-K | 2022-11-30 | 2022-08-31 | |
| 8-K | 2022-07-25 | 2022-07-20 | |
| 10-Q | 2022-07-14 | 2022-05-31 | |
| 8-K | 2022-05-13 | 2022-05-10 | |
| 10-Q | 2022-04-12 | 2022-02-28 | |
| 8-K | 2022-03-28 | — | |
| 8-K | 2022-03-16 | 2022-03-11 | |
| 8-K | 2022-02-17 | 2022-02-15 | |
| 10-Q | 2022-01-13 | 2021-11-30 | |
| 10-K | 2021-11-29 | 2021-08-31 | |
| 8-K | 2021-11-19 | 2021-11-16 | |
| 8-K | 2021-09-13 | 2021-09-03 | |
| 8-K | 2021-07-19 | 2021-07-15 | |
| 10-Q | 2021-07-14 | 2021-05-31 | |
| 8-K | 2021-07-06 | 2021-07-01 | |
| 8-K | 2021-04-28 | 2021-04-23 | |
| 10-Q | 2021-04-14 | 2021-02-28 | |
| 10-Q | 2021-01-14 | 2020-11-30 | |
| 8-K | 2020-12-21 | 2020-12-16 | |
| 8-K | 2020-11-16 | — | |
| 10-K | 2020-11-04 | 2020-08-31 | |
| 8-K | 2020-09-02 | — | |
| 10-Q | 2020-07-14 | 2020-05-31 | |
| 8-K | 2020-04-17 | 2020-04-16 | |
| 10-Q | 2020-04-13 | 2020-02-29 | |
| 10-Q | 2020-01-14 | 2019-11-30 |
Showing 1–45 of 45 filings